Inactive Instrument
TxCell Share Price CBOE
Stocks
0QTN
FR0010127662
Biotechnology & Medical Research
|
End-of-day quote
CBOE
|
||
| - EUR | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Sandrine Boulet
COO | Chief Operating Officer | 50 | - |
| Corporate Officer/Principal | - | - | |
Bernard Malissen
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Duncan Mckay
CHM | Chairman | - | 12/02/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.80% | +3.44% | +70.64% | +109.32% | 7.33TCr | |
| -0.65% | +13.43% | +48.17% | +89.35% | 6.2TCr | |
| +3.70% | -4.77% | +0.41% | +484.07% | 2.8TCr | |
| +5.24% | +5.65% | +56.71% | +21.30% | 2.41TCr | |
| -1.60% | -1.29% | -19.31% | -19.10% | 2.3TCr | |
| -6.00% | +6.02% | +244.39% | +430.80% | 1.83TCr | |
| +0.76% | +6.27% | +40.50% | -13.73% | 1.95TCr | |
| +3.83% | +2.65% | +21.42% | +557.58% | 1.59TCr | |
| +2.11% | -1.21% | +36.57% | +149.14% | 1.3TCr | |
| Average | +1.35% | +1.06% | +55.50% | +200.97% | 3.08TCr | |
| Weighted average by Cap. | +1.80% | +3.14% | +54.80% | +164.68% |
Employees
-
- Stock Market
- Stocks
- TXCL Stock
- 0QTN Stock
Select your edition
All financial news and data tailored to specific country editions
